CME Group Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de CME Group de 3.4% y 4.3% por año respectivamente. Se prevé que el BPA crezca en un 3.5% al año. Se espera que la rentabilidad financiera sea de 13.3% en 3 años.
Información clave
3.4%
Tasa de crecimiento de los beneficios
3.4%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Capital Markets | 15.7% |
Tasa de crecimiento de los ingresos | 4.3% |
Rentabilidad financiera futura | 12.9% |
Cobertura de analistas | Good |
Última actualización | 26 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely
Dec 27Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors
Nov 14We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation
Apr 28CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year
Dec 15CME Group ADV climbs 21% Y/Y to 6.1M in Q3
Oct 11CME Group Is The Perfect Dividend Stock To Buy While It's Cheap
Sep 30CME Group launches ethereum options ahead of this week's blockchain Merge
Sep 12With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case
Sep 08CME Group proposes converting eurodollar futures, options contracts to SOFR
Sep 06CME Group launches bitcoin Euro and ether Euro futures
Aug 29CME Group set to launch ether futures options in September
Aug 18CME Group ADV perks up 20% in July in wake of volatile markets
Aug 02CME Q2 2022 Earnings Preview
Jul 26CME achieves 21% growth in Q2 international ADV
Jul 12CME Group average daily volume jumps to 24M contracts in June
Jul 05CME Nears A Do-Or-Die Moment
May 27Why CME Should Be In Our Dividend Growth Portfolios
Apr 30Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 6,492 | 3,653 | 3,984 | N/A | 8 |
12/31/2025 | 6,133 | 3,487 | 3,773 | N/A | 14 |
12/31/2024 | 5,919 | 3,448 | 3,745 | N/A | 14 |
3/31/2024 | 5,615 | 3,157 | N/A | N/A | N/A |
12/31/2023 | 5,569 | 3,186 | 3,377 | 3,454 | N/A |
9/30/2023 | 5,338 | 3,011 | 3,311 | 3,391 | N/A |
6/30/2023 | 5,228 | 2,942 | 3,108 | 3,192 | N/A |
3/31/2023 | 5,104 | 2,828 | 3,078 | 3,159 | N/A |
12/31/2022 | 5,009 | 2,657 | 2,966 | 3,056 | N/A |
9/30/2022 | 4,833 | 2,633 | 2,650 | 2,743 | N/A |
6/30/2022 | 4,715 | 2,889 | 2,616 | 2,717 | N/A |
3/31/2022 | 4,657 | 2,745 | 2,477 | 2,599 | N/A |
12/31/2021 | 4,690 | 2,617 | 2,275 | 2,402 | N/A |
9/30/2021 | 4,630 | 2,435 | 2,225 | 2,394 | N/A |
6/30/2021 | 4,600 | 1,920 | 1,888 | 2,074 | N/A |
3/31/2021 | 4,603 | 1,913 | 2,378 | 2,561 | N/A |
12/31/2020 | 4,884 | 2,105 | 2,518 | 2,716 | N/A |
9/30/2020 | 4,911 | 2,151 | 2,581 | 2,775 | N/A |
6/30/2020 | 5,109 | 2,375 | 3,071 | 3,274 | N/A |
3/31/2020 | 5,200 | 2,386 | 2,521 | 2,761 | N/A |
12/31/2019 | 4,868 | 2,117 | 2,427 | 2,673 | N/A |
9/30/2019 | 4,959 | 2,033 | 2,229 | 2,464 | N/A |
6/30/2019 | 4,588 | 1,808 | 2,027 | 2,236 | N/A |
3/31/2019 | 4,377 | 1,860 | 2,137 | 2,285 | N/A |
12/31/2018 | 4,309 | 1,962 | 2,324 | 2,441 | N/A |
9/30/2018 | 3,973 | 4,516 | 2,301 | 2,391 | N/A |
6/30/2018 | 3,959 | 4,413 | 2,242 | 2,316 | N/A |
3/31/2018 | 3,824 | 4,262 | 1,977 | 2,057 | N/A |
12/31/2017 | 3,645 | 4,063 | N/A | 1,751 | N/A |
9/30/2017 | 3,658 | 1,498 | N/A | 1,801 | N/A |
6/30/2017 | 3,609 | 1,662 | N/A | 1,773 | N/A |
3/31/2017 | 3,590 | 1,566 | N/A | 1,732 | N/A |
12/31/2016 | 3,595 | 1,534 | N/A | 1,732 | N/A |
9/30/2016 | 3,496 | 1,452 | N/A | 1,607 | N/A |
6/30/2016 | 3,505 | 1,340 | N/A | 1,591 | N/A |
3/31/2016 | 3,418 | 1,284 | N/A | 1,626 | N/A |
12/31/2015 | 3,327 | 1,247 | N/A | 1,533 | N/A |
9/30/2015 | 3,354 | 1,262 | N/A | 1,644 | N/A |
6/30/2015 | 3,266 | 1,192 | N/A | 1,414 | N/A |
3/31/2015 | 3,178 | 1,191 | N/A | 1,327 | N/A |
12/31/2014 | 3,113 | 1,127 | N/A | 1,291 | N/A |
9/30/2014 | 2,958 | 1,014 | N/A | 1,171 | N/A |
6/30/2014 | 2,911 | 960 | N/A | 1,066 | N/A |
3/31/2014 | 2,990 | 1,008 | N/A | 1,268 | N/A |
12/31/2013 | 2,931 | 977 | N/A | 1,281 | N/A |
9/30/2013 | 2,905 | 951 | N/A | 1,221 | N/A |
6/30/2013 | 2,874 | 932 | N/A | 1,331 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (3.6% al año) de CME es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (3.4% al año) de CME crezcan menos que el mercado US (14.4% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de CME crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (4.3% al año) de CME crezcan más despacio que el mercado de US (7.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.3% al año) de CME crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CME sea baja dentro de 3 años (13.3%).